Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DCGO DocGo	$1.46 +0.7%	$1.50	$1.23 ▼ $5.68	$148.90M	0.97	531,024 shs	256,092 shs
KDLY Kindly MD	$10.97 +0.6%	$15.62	$0.65 ▼ $34.77	$66.06M	N/A	2.29 million shs	101,294 shs
VMD Viemed Healthcare	$6.12 -2.7%	$6.72	$6.10 ▼ $9.81	$241.89M	1.37	216,913 shs	512,946 shs
XGN Exagen	$7.27 +0.7%	$6.98	$1.78 ▼ $7.95	$154.85M	1.58	267,628 shs	95,646 shs

Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DCGO DocGo	+0.69%	+2.10%	-9.88%	-34.82%	-55.08%
KDLY Kindly MD	-5.71%	-4.64%	-28.80%	+502.21%	+238.51%
VMD Viemed Healthcare	-2.70%	-5.70%	-12.32%	-13.44%	-16.85%
XGN Exagen	+0.69%	+3.86%	+7.39%	+17.07%	+276.68%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
DCGO DocGo	2.0508 of 5 stars	3.3	1.0	0.0	0.0	2.3	2.5	0.6
KDLY Kindly MD	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
VMD Viemed Healthcare	1.8679 of 5 stars	0.0	2.0	0.0	0.0	3.5	3.3	1.3
XGN Exagen	4.1825 of 5 stars	3.5	2.0	0.0	4.5	2.0	2.5	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
DCGO DocGo	2.50	Moderate Buy	$3.56	143.84% Upside
KDLY Kindly MD	0.00	N/A	N/A	N/A
VMD Viemed Healthcare	0.00	N/A	N/A	N/A
XGN Exagen	3.00	Buy	$9.00	23.80% Upside

Current Analyst Ratings Breakdown

Latest KDLY, VMD, XGN, and DCGO Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/23/2025	XGN Exagen	Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$12.00
5/15/2025	XGN Exagen	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight
5/15/2025	XGN Exagen	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$8.00 ➝ $7.00
5/13/2025	XGN Exagen	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$7.00 ➝ $8.00
5/12/2025	DCGO DocGo	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Hold	$5.00 ➝ $1.45
5/9/2025	DCGO DocGo	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$4.00 ➝ $3.00
5/9/2025	DCGO DocGo	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Neutral
5/7/2025	XGN Exagen	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy

(Data available from 7/26/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
DCGO DocGo	$616.55M	0.24	$0.43 per share	3.43	$3.09 per share	0.47
KDLY Kindly MD	$2.47M	26.74	N/A	N/A	N/A	∞
VMD Viemed Healthcare	$232.79M	1.04	$0.91 per share	6.69	$3.41 per share	1.79
XGN Exagen	$56.72M	2.73	N/A	N/A	$0.54 per share	13.46

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
DCGO DocGo	$19.99M	-$0.02	N/A	18.25	N/A	-0.12%	2.52%	1.70%	8/7/2025 (Estimated)
KDLY Kindly MD	N/A	-$0.77	N/A	∞	N/A	N/A	N/A	N/A	N/A
VMD Viemed Healthcare	$11.27M	$0.30	20.40	∞	N/A	5.28%	9.49%	7.14%	8/6/2025 (Estimated)
XGN Exagen	-$15.11M	-$0.84	N/A	N/A	N/A	-27.34%	-133.69%	-34.87%	7/29/2025 (Estimated)

Latest KDLY, VMD, XGN, and DCGO Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/7/2025	Q2 2025	DCGO DocGo	-$0.06	N/A	N/A	N/A	$77.58 million	N/A
7/29/2025	Q2 2025	XGN Exagen	-$0.18	N/A	N/A	N/A	$16.25 million	N/A
5/12/2025	Q1 2025	XGN Exagen	-$0.20	-$0.20	N/A	-$0.20	$14.55 million	$15.50 million
5/8/2025	Q1 2025	DCGO DocGo	-$0.01	-$0.09	-$0.08	-$0.09	$104.25 million	$96.03 million
5/8/2025	Q1 2025	KDLY Kindly MD	N/A	-$0.17	N/A	-$0.17	N/A	N/A
5/7/2025	Q1 2025	VMD Viemed Healthcare	$0.06	$0.06	N/A	$0.06	$60.60 million	$59.10 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
DCGO DocGo	N/A	N/A	N/A	N/A	N/A
KDLY Kindly MD	N/A	N/A	N/A	N/A	N/A
VMD Viemed Healthcare	N/A	N/A	N/A	N/A	N/A
XGN Exagen	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
DCGO DocGo	N/A	2.44	2.44
KDLY Kindly MD	N/A	5.43	5.42
VMD Viemed Healthcare	0.03	1.38	1.26
XGN Exagen	2.87	2.32	2.32

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
DCGO DocGo	56.44%
KDLY Kindly MD	N/A
VMD Viemed Healthcare	74.24%
XGN Exagen	75.25%

Insider Ownership

Company	Insider Ownership
DCGO DocGo	2.70%
KDLY Kindly MD	50.50%
VMD Viemed Healthcare	20.00%
XGN Exagen	12.60%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
DCGO DocGo	4,407	101.98 million	99.23 million	Optionable
KDLY Kindly MD	N/A	6.02 million	2.96 million	N/A
VMD Viemed Healthcare	1,179	39.52 million	31.62 million	Not Optionable
XGN Exagen	220	21.30 million	18.62 million	Optionable

KDLY, VMD, XGN, and DCGO Headlines

Recent News About These Companies

Craig-Hallum Initiates Coverage of Exagen (XGN) with Buy Recommendation

July 25 at 4:50 PM | msn.com

Exagen Inc. (XGN): A Bull Case Theory

July 24 at 12:07 PM | msn.com

Exagen (XGN) Soars 5.5%: Is Further Upside Left in the Stock?

July 24 at 9:45 AM | zacks.com

TD Cowen Remains a Buy on Exagen (XGN)

July 23 at 12:19 PM | theglobeandmail.com

Exagen Inc. (NASDAQ:XGN) Given Consensus Rating of "Buy" by Analysts

July 23 at 10:26 AM | marketbeat.com

Exagen (NASDAQ:XGN) Earns Buy Rating from Analysts at Craig Hallum

July 23 at 8:39 AM | marketbeat.com

Exagen (XGN) to Release Quarterly Earnings on Tuesday

July 22, 2025 | marketbeat.com

Exagen (NASDAQ:XGN) versus Varex Imaging (NASDAQ:VREX) Head to Head Review

July 18, 2025 | americanbankingnews.com

Exagen Inc. Appoints Chas McKhann to Board of Directors

July 17, 2025 | globenewswire.com

Exagen Inc. to Announce Second Quarter 2025 Financial Results on July 29, 2025

July 15, 2025 | globenewswire.com

Exagen Insider Ups Holding During Year

June 29, 2025 | finance.yahoo.com

2025-06-23 | Michael Mahler, PhD Joins Exagen as Chief Scientific Officer to Enhance Leadership in Autoimmune Diagnostics | NDAQ:XGN | Press Release - Stockhouse

June 24, 2025 | stockhouse.com

Michael Mahler, PhD Joins Exagen as Chief Scientific Officer to Enhance Leadership in Autoimmune Diagnostics

June 23, 2025 | globenewswire.com

Exagen announces resale of up to 1.15M shares

June 20, 2025 | msn.com

Exagen Inc. Holds 2025 Annual Stockholder Meeting

June 11, 2025 | tipranks.com

Exagen Inc. (NASDAQ:XGN) Q1 2025 Earnings Call Transcript

May 11, 2025 | insidermonkey.com

Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of Underwriter’s Option to Purchase Additional Shares

May 9, 2025 | finance.yahoo.com

Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of Underwriter's Option to Purchase Additional Shares

May 9, 2025 | globenewswire.com

Exagen Inc. Prices Public Offering of Common Stock

May 8, 2025 | globenewswire.com

KeyBanc maintains Exagen stock at Sector Weight

May 7, 2025 | investing.com

KeyBanc maintains Exagen stock at Sector Weight

May 7, 2025 | investing.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

KDLY, VMD, XGN, and DCGO Company Descriptions

DocGo NASDAQ:DCGO

$1.46 +0.01 (+0.69%)

Closing price 07/25/2025 04:00 PM Eastern

Extended Trading

$1.49 +0.03 (+2.05%)

As of 07/25/2025 07:29 PM Eastern

DocGo Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home, offices, and other locations; event services, which include on-site healthcare support at sporting events and concerts; and total care management solutions comprising healthcare services and ancillary services, such as shelter. DocGo Inc. was founded in 2015 and is headquartered in New York, New York.

Kindly MD NASDAQ:KDLY

$10.97 +0.07 (+0.64%)

As of 07/25/2025

Kindly MD, Inc. provides healthcare services. Its services include medication management, behavioral healthcare and alternative treatments. The firm offers evaluation and management, including chronic pain, functional medicine, cognitive behavioral therapy, trauma and addiction therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, travel services, and hormone therapy. The company was founded by Timothy Pickett in December 2019 and is headquartered in Murray, UT.

Viemed Healthcare NASDAQ:VMD

$6.12 -0.17 (-2.70%)

Closing price 07/25/2025 04:00 PM Eastern

Extended Trading

$6.38 +0.26 (+4.18%)

As of 07/25/2025 07:56 PM Eastern

Viemed Healthcare, Inc., together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment; and sells and rents HME devices. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.

Exagen NASDAQ:XGN

$7.27 +0.05 (+0.69%)

Closing price 07/25/2025 04:00 PM Eastern

Extended Trading

$7.26 0.00 (-0.07%)

As of 07/25/2025 07:26 PM Eastern

Exagen Inc. develops and commercializes various testing products under the AVISE brand in the United States. The company enables healthcare providers to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Its lead testing product is AVISE CTD that enables differential diagnosis for patients presenting with symptoms indicative of various connective tissue diseases (CTDs) and other related diseases with overlapping symptoms. The company offers AVISE Lupus that measures activation of the complement system by quantifying the level of B-cell C4d and erythrocyte bound C4d in the patient's blood; and AVISE APS, which consists of a panel of autoantibody tests that aids in the diagnosis and management of APS. In addition, it provides AVISE Vasculitis AAV, which utilizes a testing panel of individual analytes to provide physicians with results in the assessment and monitoring of anti-neutrophil cytoplasmic antibody associated vasculitis; AVISE SLE Prognostic, a panel of autoantibodies for assessing the potential for complications affecting the kidney, brain, and cardiovascular system; and AVISE Anti-CarP test, which identifies RA patients with severe disease. Further, the company offers AVISE SLE Monitor, a biomarker blood test; AVISE MTX, a patented and validated blood test; and AVISE HCQ, a blood test to monitor levels of hydroxychloroquine. It has a research collaboration and license agreement with Allegheny Health Network (AHN) Research Institute to develop novel patented biomarkers. The company was formerly known as Exagen Diagnostics, Inc. and changed its name to Exagen Inc. in January 2019. Exagen Inc. was incorporated in 2002 and is headquartered in Vista, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time